Home/Filings/4/0001104659-24-128471
4//SEC Filing

Plant Michael P. 4

Accession 0001104659-24-128471

CIK 0001958140other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:40 PM ET

Size

14.7 KB

Accession

0001104659-24-128471

Insider Transaction Report

Form 4
Period: 2024-12-11
Plant Michael P.
EVP, Development
Transactions
  • Exercise/Conversion

    Restricted Stock Units - BATRK

    2024-12-1111,14222,284 total
    Series C Common Stock (11,142 underlying)
  • Exercise/Conversion

    Series C Common Stock

    2024-12-11+11,142289,533 total
  • Exercise/Conversion

    Series C Common Stock

    2024-12-11+22,284278,391 total
  • Sale

    Series C Common Stock

    2024-12-12$39.93/sh14,940$596,554274,593 total
  • Exercise/Conversion

    Restricted Stock Units - BATRK

    2024-12-1122,2840 total
    From: 2024-12-11Exp: 2024-12-11Series C Common Stock (22,284 underlying)
Holdings
  • Series C Common Stock

    (indirect: By Trust)
    78,128
Footnotes (6)
  • [F1]Each restricted stock unit converted into one share of Series C Common Stock.
  • [F2]Reflects 21,175 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation.
  • [F3]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
  • [F4]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $39.76 to $40.26.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
  • [F6]One-third of the restricted stock unit award vested on December 11, 2024, and the remaining restricted stock units vest in substantially equal installments on each of December 11, 2025 and 2026.

Issuer

Atlanta Braves Holdings, Inc.

CIK 0001958140

Entity typeother

Related Parties

1
  • filerCIK 0002036190

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:40 PM ET
Size
14.7 KB